Target BioScience AG, Rüschlikon/Zurich, Switzerland

A Selection of Expertise in Medical Marketing Services

Prescription Event Monitoring (PEM) Surveys

Various PEM-surveys had been performed with:

  • Antidepressants (i.g. paroxetin)*
  • Antismoking drugs (i.g. bupropion)*
  • Antidiabetics (i.g. rosiglitazon)*
  • Antiasthmatics (i.g. salmeterol and fluticason)*
  • Antimigraine drugs (i.g. sumatriptan, naratriptan)*
  • Analgesics
  • Hair growth stimulants, alopecia
  • Vaccines
     

*see also publications

 

Marketing Support

  • Concepts for marketing activities had been performed with various drugs:
    - antidepressents
    - antifinfectives
    - contrast media
    - erythropoietins
    - interferons
    - vaccine
  • Product positioning for various drugs, including a hospital reserve antibiotic: Analysis of expert panels.
  • Market research*: Expectations of a new contraceptive (ethinylestradiol / drosipirenone): Results of a survey with 7'385 women.
  • Market research: A survey with different contraceptives.
     

*see also publications

 

Data Management and Statistics

  • Multi-center, open observational study to investigate the effects of rofecoxib on quality of life in elderly out-patients with painful osteoarthritis of the hip or knee.*
  • WOMAC questionnaire validation: Comparison between the two forms «paper-» and «computer-version».
  • Quality of life during the first 24 months in patients with relapsing-remitting and secondary progressive multiple sclerosis treated with interferon beta.
  • Efficacy and safety of rosiglitazon in patiens with diabetes type 2.*
  • Photographic assessment of patients with androgenetic alopecia treated with a 5-alpha-reductase inhibitor.
  • Efficacy and safety of antacida and antiinfectives in the eradication Helicobacter Pylori: A multi-center, double-blind, placebo-cpontrolled trial.
  • Efficacy and safety of an antacid used as effervescent powder or as tablet: A multicenter, randomized, crossover study.
  • Efficacy and Safety of corticosteroid in the treament of eczema.
  • A randomized, comparative, multi-center study of an antiinfective drug versus a combination therapy of two antiinfective drugs in the treatment of serious lower respiratory tract infections.
  • An open multi-centre study to evaluate the efficacy, safety and tolerability of a triptan in migraine patients.
  • A local double-blind, placebo-controlled, randomised multi-center study to evaluate the efficacy, tolerance and safety of corticosteroid in the treatment of nasal polyps.
     

*see also publications